{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:35:47Z","timestamp":1765038947202},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,2,28]],"date-time":"2001-02-28T00:00:00Z","timestamp":983318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Pediatr. Oncol."],"published-print":{"date-parts":[[2001,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Minimal residual disease (MRD) detected during remission might predict outcome in children with acute lymphoblastic leukemia. No population\u2010based studies have been carried out. We studied all children with ALL presenting over 5 years within a defined population to determine its clinical importance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Procedure<\/jats:title><jats:p>Patients were investigated for the presence of unique clonal rearrangements of IgH and T\u2010cell receptor genes. Unique patient specific probes were used to detect, by polymerase chain reaction, the presence of clonal markers indicating MRD in mononuclear cells obtained from marrow samples at 1, 3, 5, and 24 months. The effect of MRD on event\u2010free survival was determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy\u2010seven of 120 children with ALL had informative markers and samples of remission marrow suitable for testing. Presence or absence of MRD did not significantly affect outcome. Gender (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.04) and white cell count (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.04) were independent prognostic factors. Analysis of only those cases with detectable MRD showed that cases with one blast per 100 mononuclear cells, or more, 28 days after starting treatment did worse than those with lower levels (hazard ratio 7.77, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.02).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Mere presence or absence of MRD is probably too crude a measure to be useful and worse than other standard prognostic indicators. A threshold of 10<jats:sup>\u22122<\/jats:sup> blasts at 28 days might be discriminatory, but should not be over\u2010interpreted. The number of patients available for this analysis (31) was small, the threshold and sampling points were arbitrary and any effects could be treatment regimen\u2010specific. Large prospective studies are needed. Med. Pediatr. Oncol. 36:365\u2013371, 2001. \u00a9 2001 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/mpo.1087","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T18:04:33Z","timestamp":1030298673000},"page":"365-371","source":"Crossref","is-referenced-by-count":6,"title":["A demographic study of the clinical significance of minimal residual disease in children with acute lymphoblastic leukemia"],"prefix":"10.1002","volume":"36","author":[{"given":"D.","family":"Levett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,2,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401065"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<106::AID-MPO6>3.0.CO;2-L"},{"key":"e_1_2_1_4_2","first-page":"60","article-title":"Characterisation of non\u2010concordance in the T\u2010cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia","volume":"8","author":"Taylor JJ","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood.V83.5.1355.1355","article-title":"A polymerase chain reaction study of the stability of Ig heavy chain and T\u2010cell receptor gene rearrangements between presentation and relapse of childhood B\u2010lineage acute lymphoblastic leukemia","volume":"83","author":"Steward CG","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V77.2.331.331","article-title":"Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients","volume":"77","author":"Yokota S","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4781(91)90044-M"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.13.5123"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1182\/blood.V86.10.3930.bloodjournal86103930","article-title":"Analysis of rearranged T\u2010cell receptor B\u2010chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis","volume":"86","author":"Kneba M","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood.V81.8.2110.2110","article-title":"Clinical features and outcome of T\u2010cell acute lymphoblastic leukemia in childhood with respect to alterations in the Tal 1 locus: a Pediatric Oncology Group Study","volume":"81","author":"Bash RO","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199402150-00024"},{"key":"e_1_2_1_12_2","first-page":"46","article-title":"Accurate quantitation of residual B\u2010precursor acute lymphoblastic leukemia by limiting dilution and a PCR\u2010based detection system: a description of the method and the principles involved","volume":"8","author":"Ouspenskaia MV","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00574.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood.V84.4.1352.1352","article-title":"False positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia","volume":"84","author":"Langlands K","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1999.01365.x","article-title":"Investigation of minimal residual disease in childhood and adult lympho\u2010blastic leukaemia by molecular analysis","volume":"105","author":"Foroni L","year":"1999","journal-title":"Br J Haematol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390904"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04058-6"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701303360501"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401780"}],"container-title":["Medical and Pediatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpo.1087","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.1087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T17:26:25Z","timestamp":1700414785000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.1087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,28]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["10.1002\/mpo.1087"],"URL":"https:\/\/doi.org\/10.1002\/mpo.1087","archive":["Portico"],"relation":{},"ISSN":["0098-1532","1096-911X"],"issn-type":[{"value":"0098-1532","type":"print"},{"value":"1096-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2,28]]}}}